E Alberdi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

E Alberdi

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Journal of Pharmaceutical Sciences|May 1, 1993

A novel class of cardiotonic agents: synthesis and biological evaluation of pyridazino[4,5-b]indoles with cyclic AMP phosphodiesterases inhibiting propertiesA Monge, I Aldana, M J Losa, et al.

Molecular Psychiatry|July 12, 2017

Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradationY Akwa, E Gondard, A Mann, et al.

Archiv Der Pharmazie|July 1, 1992

New indole and triazino[5,4-b]indol-4-one derivatives: synthesis and studies as inotropics and inhibitors of blood platelet aggregationA Monge, I Aldana, M Font, et al.

Archiv Der Pharmazie|November 1, 1993

New 4-amino-7,8-dimethoxy-5H-pyrimido[5,4-b]indole derivatives: synthesis and studies as inhibitors of phosphodiesterasesA Monge, F J Martínez-Crespo, M A Villanueva, et al.

Translational Psychiatry|January 24, 2013

1-42 β-amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal deathL Manterola, M Hernando-Rodríguez, A Ruiz, et al.

Drug Design and Discovery|April 1, 1997

Synthesis and evaluation of new Reissert analogs as HIV-1 reverse transcriptase inhibitors. 1. Quinoline and quinoxaline derivativesM Font, A Monge, E Alvarez, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Journal of Pharmaceutical Sciences|May 1, 1993

A novel class of cardiotonic agents: synthesis and biological evaluation of pyridazino[4,5-b]indoles with cyclic AMP phosphodiesterases inhibiting propertiesA Monge, I Aldana, M J Losa, et al.

Molecular Psychiatry|July 12, 2017

Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradationY Akwa, E Gondard, A Mann, et al.

Archiv Der Pharmazie|July 1, 1992

New indole and triazino[5,4-b]indol-4-one derivatives: synthesis and studies as inotropics and inhibitors of blood platelet aggregationA Monge, I Aldana, M Font, et al.

Archiv Der Pharmazie|November 1, 1993

New 4-amino-7,8-dimethoxy-5H-pyrimido[5,4-b]indole derivatives: synthesis and studies as inhibitors of phosphodiesterasesA Monge, F J Martínez-Crespo, M A Villanueva, et al.

Translational Psychiatry|January 24, 2013

1-42 β-amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal deathL Manterola, M Hernando-Rodríguez, A Ruiz, et al.

Drug Design and Discovery|April 1, 1997

Synthesis and evaluation of new Reissert analogs as HIV-1 reverse transcriptase inhibitors. 1. Quinoline and quinoxaline derivativesM Font, A Monge, E Alvarez, et al.

Pageof 3